Rui Tian
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 3
-
- Pancreatic and Hepatic Oncology Research 3
-
- CRISPR and Genetic Engineering 9
- RNA and protein synthesis mechanisms 4
-
- Virus-based gene therapy research 4
-
- Plant Virus Research Studies 3
In The Last Decade
Rui Tian
40 papers receiving 564 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 110
- Oncology 184
- Business and International Management 13
- Immunology 110
- Geriatrics and Gerontology 18
Countries citing papers authored by Rui Tian
This map shows the geographic impact of Rui Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Tian more than expected).
Fields of papers citing papers by Rui Tian
This network shows the impact of papers produced by Rui Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Tian. The network helps show where Rui Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rui Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 24 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 29 | |
| 12 | 2022 | 15 | |
| 13 | 2021 | 2 | |
| 14 | ADAMTS8 Inhibits Cell Proliferation and Invasion, and Induces Apoptosis in Breast Cancer | 2020 | 3 |
| 15 | 2020 | 4 | |
| 16 | 2020 | 10 | |
| 17 | 2019 | 2 | |
| 18 | Simultaneous Determination of Protocatechuic Acid, Lobetyolin, Atractylodes Lactone I , II and III in Xiangsha Liujun Pills by HPLC-MS | 2019 | 0 |
| 19 | 2018 | 8 | |
| 20 | 2011 | 14 |
About Rui Tian
Rui Tian is a scholar working on Cancer Research, Geriatrics and Gerontology and Molecular Biology, having authored 44 papers that have together received 571 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (9 papers), Virus-based gene therapy research (4 papers), Cancer-related molecular mechanisms research (4 papers), RNA and protein synthesis mechanisms (4 papers), MicroRNA in disease regulation (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Plant Virus Research Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (110 citations), Oncology (184 citations) and Business and International Management (13 citations). Rui Tian has collaborated with scholars based in China, Macao and Australia. Frequent co-authors include Chengjian Shi, Zhiyong Du, Chenghong Peng, Renyi Qin, Emidio Capriotti, Malay Kumar Basu, Bicheng Yong, Jingnan Shen, Tingsheng Peng and Canqiao Luo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.